HSBC Holdings Portfolio holdings
HSBC Holdings plc, founded in 1865 as the Hongkong and Shanghai Banking Corporation by Sir Thomas Sutherland to finance trade in East Asia, is a British multinational bank headquartered in London, managing trillions in assets as one of the world’s largest banking and financial services organizations. Operating in over 60 countries with a strong emphasis on Asia—where it generates much of its revenue—HSBC offers retail banking, wealth management, commercial banking, and global markets services to more than 40 million customers, supported by around 214,000 employees as of late 2024. Known for its international network and resilience through crises like the 1997 Asian financial downturn, HSBC has pivoted under Group CEO Noel Quinn (since 2020) to accelerate digital transformation and sustainability goals, targeting net-zero emissions by 2050. Despite challenges like geopolitical tensions and regulatory pressures, HSBC remains a cornerstone of global finance, leveraging its heritage as a trade financier into a modern, Asia-centric banking powerhouse.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$297M |
| 2 |
Amazon
AMZN
|
+$251M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$230M |
| 4 |
Apple
AAPL
|
+$207M |
| 5 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$206M |
| 2 |
AGN
Allergan plc
AGN
|
+$203M |
| 3 |
RTX Corp
RTX
|
+$120M |
| 4 |
Berkshire Hathaway Class A
BRK.A
|
+$106M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$104M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 21.06% |
| 2 | Technology | 17.57% |
| 3 | Healthcare | 9.01% |
| 4 | Financials | 8.94% |
| 5 | Communication Services | 7.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
APLS
2226
DELISTED
Apellis Pharmaceuticals
APLS
| $248K | ﹤0.01% |
+7,580
| New | +$243K |
|
2227
Aurinia Pharmaceuticals
AUPH
$1.93B
| $248K | ﹤0.01% |
+15,250
| New | +$244K |
|
2228
Clear Channel Outdoor Holdings
CCO
$1.23B
| $248K | ﹤0.01% |
238,559
+7,352
| +3% | +$6.91K |
|
2229
Colliers International
CIGI
$5.08B
| $248K | ﹤0.01% |
4,335
-2,427
| -36% | -$130K |
|
2230
Hilltop Holdings
HTH
$2.26B
| $248K | ﹤0.01% |
13,432
-1,022
| -7% | -$17.6K |
|
2231
CALL
BioMarin Pharmaceuticals
BMRN
$11.7B
| $247K | ﹤0.01% |
+2,000
| New | +$199K |
|
|
TPC
2232
Tutor Perini Cor
TPC
$4.38B
| $247K | ﹤0.01% |
20,271
-6,706
| -25% | -$60K |
|
2233
CoreCivic
CXW
$2.95B
| $246K | ﹤0.01% |
26,234
-13,506
| -34% | -$154K |
|
|
PPD
2234
DELISTED
PPD, Inc. Common Stock
PPD
| $246K | ﹤0.01% |
+9,183
| New | +$229K |
|
|
IMMU
2235
DELISTED
Immunomedics Inc
IMMU
| $245K | ﹤0.01% |
+6,920
| New | +$202K |
|
|
ESSA
2236
DELISTED
ESSA Bancorp
ESSA
| $244K | ﹤0.01% |
17,514
+5,110
| +41% | +$65.9K |
|
2237
Independent Bank Corp
IBCP
$787M
| $244K | ﹤0.01% |
+16,427
| New | +$227K |
|
|
TVRD
2238
Tvardi Therapeutics
TVRD
$19.7M
| $244K | ﹤0.01% |
+397
| New | +$219K |
|
|
HTZ
2239
DELISTED
Hertz Global Holdings, Inc.
HTZ
| $244K | ﹤0.01% |
172,910
-211,578
| -55% | -$671K |
|
2240
WisdomTree Europe SmallCap Dividend Fund
DFE
$167M
| $242K | ﹤0.01% |
4,890
-996
| -17% | -$45.8K |
|
2241
Genworth Financial
GNW
$3.81B
| $242K | ﹤0.01% |
104,593
+24,521
| +31% | +$77.2K |
|
2242
Veracyte
VCYT
$4.77B
| $241K | ﹤0.01% |
+9,322
| New | +$232K |
|
|
CRON
2243
Cronos Group
CRON
$1.08B
| $240K | ﹤0.01% |
39,967
-23,029
| -37% | -$141K |
|
2244
CALL
Cintas
CTAS
$82.7B
| $240K | ﹤0.01% |
+3,600
| New | +$208K |
|
2245
Iovance Biotherapeutics
IOVA
$2.09B
| $239K | ﹤0.01% |
+8,693
| New | +$286K |
|
2246
NI Holdings
NODK
$314M
| $239K | ﹤0.01% |
+16,206
| New | +$220K |
|
2247
Metallus
MTUS
$826M
| $239K | ﹤0.01% |
61,471
-15,920
| -21% | -$53.2K |
|
2248
Boyd Gaming
BYD
$6.47B
| $238K | ﹤0.01% |
11,377
-79,113
| -87% | -$1.44M |
|
2249
iShares Global Clean Energy ETF
ICLN
$2.33B
| $238K | ﹤0.01% |
19,000
+9,000
| +90% | +$101K |
|
|
K
2250
PUT
DELISTED
Kellanova
K
| $238K | ﹤0.01% |
3,834
-14,058
| -79% | -$851K |
|
Similar funds
HSBC Holdings's Q2 2020 Portfolio in Review
As of Q2 2020, HSBC Holdings held 2,977 positions worth $52.7B, up 22% from $43.1B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
HSBC Holdings's Q2 2020 filing shows 324 new, 916 increased, 1,270 reduced and 352 closed positions. Its largest new stake was Otis Worldwide: 699,966 shares worth $39.8M. The largest sale was Alibaba, an estimated $206M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 21% of assets, up from 20% a quarter earlier, followed by Technology and Healthcare.
- HSBC Holdings's largest Q2 2020 buy was Otis Worldwide: 699,966 shares worth $39.8M.
- HSBC Holdings added most to Microsoft in Q2 2020, an estimated $297M increase.
- HSBC Holdings's biggest Q2 2020 reduction was Alibaba, cutting an estimated $206M.
- HSBC Holdings fully exited Allergan plc in Q2 2020, selling an estimated $203M.
- HSBC Holdings's ten largest holdings make up 29% of its $52.7B portfolio in Q2 2020.
- HSBC Holdings opened 324 new positions and closed 352 in Q2 2020.
- HSBC Holdings's portfolio value rose 22% quarter-over-quarter to $52.7B.
Based on HSBC Holdings's 13F filing for Q2 2020, filed 14 Aug 2020.